The 8th World Congress on Controversies in Multiple Myeloma (COMy) took place from May 12 - 15 2022 in Paris, France, and virtually. This meeting brought world experts together to discuss the latest controversies in multiple myeloma.
View all videos

COMy 2022

COMy 2022
12–15 May 2022 | Paris, France / Online

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

COMy 2022

COMy 2022
12–15 May 2022 | Paris, France / Online
The 8th World Congress on Controversies in Multiple Myeloma (COMy) took place from May 12 - 15 2022 in Paris, France, and virtually. This meeting brought world experts together to discuss the latest controversies in multiple myeloma.
View all videos

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter